|
1
|
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
|
Breast Cancer Res Treat
|
2009
|
1.55
|
|
2
|
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics.
|
Breast Cancer Res Treat
|
2010
|
1.20
|
|
3
|
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
|
Int J Colorectal Dis
|
2012
|
1.16
|
|
4
|
Low penetrance breast cancer predisposition SNPs are site specific.
|
Breast Cancer Res Treat
|
2008
|
1.03
|
|
5
|
Younger age as a prognostic indicator in breast cancer: a cohort study.
|
BMC Cancer
|
2011
|
0.91
|
|
6
|
miR-379 regulates cyclin B1 expression and is decreased in breast cancer.
|
PLoS One
|
2013
|
0.87
|
|
7
|
TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancer.
|
Oncologist
|
2011
|
0.85
|
|
8
|
The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
|
BMC Cancer
|
2008
|
0.80
|
|
9
|
Mismatch repair protein expression in colorectal cancer.
|
J Gastrointest Oncol
|
2013
|
0.79
|
|
10
|
A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.
|
BMC Cancer
|
2014
|
0.77
|
|
11
|
The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
|
Breast J
|
2013
|
0.75
|